BTBD19 and colorectal carcinoma: In our future studies, we plan to verify these correlations using techniques such as multiplex immunohistochemistry (IHC) or flow cytometry on independent CRC patient samples, which will help confirm the in situ distribution and functional relevance of immune cells associated with BTBD19 expression.